Sign up to save your podcasts
Or
Share Evolving Approaches in the Management of MDS
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Evolving Approaches in the Management of MDS
Review of IMerge phase 3 data on imetelstat for lower-risk MDS and how prior therapies affect treatment outcomes, and other ASCO 2025 MDS updates with Andrew Brunner, MD.
View all episodes
By Rahul Banerjee, MD
4.8
2727 ratings
Review of IMerge phase 3 data on imetelstat for lower-risk MDS and how prior therapies affect treatment outcomes, and other ASCO 2025 MDS updates with Andrew Brunner, MD.
More shows like The HemOnc Pulse
View all
JAMA Editors' Summary
136 Listeners
NEJM This Week
320 Listeners
JAMA Clinical Reviews
495 Listeners
Hematologic Oncology Update
75 Listeners
Research To Practice | Oncology Videos
118 Listeners
The Hematologist
26 Listeners
Core IM | Internal Medicine Podcast
1,158 Listeners
OncoPharm
187 Listeners
OncLive® On Air
22 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
364 Listeners
Blood Podcast
54 Listeners
Healthcare Unfiltered
136 Listeners
Blood Cancer Talks
48 Listeners
Two Onc Docs
189 Listeners
WolverHeme Happy Hour
30 Listeners